Page last updated: 2024-11-02

piribedil and Syndrome

piribedil has been researched along with Syndrome in 3 studies

Piribedil: A dopamine D2 agonist. It is used in the treatment of parkinson disease, particularly for alleviation of tremor. It has also been used for circulatory disorders and in other applications as a D2 agonist.

Syndrome: A characteristic symptom complex.

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19902 (66.67)18.7374
1990's1 (33.33)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Truy, E1
Veuillet, E1
Collet, L1
Morgon, A1
Shopsin, B1
Gershon, S1
Frediani, F1
Lamperti, E1
Avella, F1
Boiardi, A1
Graziussi, G1
Bussone, G1

Other Studies

3 other studies available for piribedil and Syndrome

ArticleYear
Characteristics of transient otoacoustic emissions in patients with sudden idiopathic hearing loss.
    British journal of audiology, 1993, Volume: 27, Issue:6

    Topics: Acute Disease; Adolescent; Adult; Aftercare; Aged; Audiometry, Pure-Tone; Cochlea; Drug Therapy, Com

1993
Dopamine receptor stimulation in the treatment of depression: piribedil (ET-495).
    Neuropsychobiology, 1978, Volume: 4, Issue:1

    Topics: Adjustment Disorders; Adult; Aged; Amphetamines; Anger; Antidepressive Agents; Bipolar Disorder; Bro

1978
[Piribedil test in cephalalgic syndromes. Diagnostic and therapeutic usefulness].
    La Clinica terapeutica, 1987, May-31, Volume: 121, Issue:4

    Topics: Adolescent; Adult; Female; Headache; Humans; Male; Middle Aged; Migraine Disorders; Piperazines; Pir

1987